ZA938728B - Process for the preparation of taxane derivatives new derivatives thus obtained and compositions which contain them - Google Patents

Process for the preparation of taxane derivatives new derivatives thus obtained and compositions which contain them

Info

Publication number
ZA938728B
ZA938728B ZA938728A ZA938728A ZA938728B ZA 938728 B ZA938728 B ZA 938728B ZA 938728 A ZA938728 A ZA 938728A ZA 938728 A ZA938728 A ZA 938728A ZA 938728 B ZA938728 B ZA 938728B
Authority
ZA
South Africa
Prior art keywords
derivatives
pct
formula
contain
preparation
Prior art date
Application number
ZA938728A
Other languages
English (en)
Inventor
Herve Bouchard
Jean-Dominique Bourzat
Alain Commercon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA938728B publication Critical patent/ZA938728B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA938728A 1992-11-23 1993-11-22 Process for the preparation of taxane derivatives new derivatives thus obtained and compositions which contain them ZA938728B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214023A FR2698363B1 (fr) 1992-11-23 1992-11-23 Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA938728B true ZA938728B (en) 1994-06-28

Family

ID=9435782

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938728A ZA938728B (en) 1992-11-23 1993-11-22 Process for the preparation of taxane derivatives new derivatives thus obtained and compositions which contain them

Country Status (23)

Country Link
US (1) US5606083A (sk)
EP (1) EP0669916B1 (sk)
JP (1) JPH08503486A (sk)
KR (1) KR950704286A (sk)
AT (1) ATE148111T1 (sk)
AU (1) AU680455B2 (sk)
CA (1) CA2149758A1 (sk)
CZ (1) CZ131795A3 (sk)
DE (1) DE69307730T2 (sk)
DK (1) DK0669916T3 (sk)
ES (1) ES2096440T3 (sk)
FI (1) FI952482A (sk)
FR (1) FR2698363B1 (sk)
GR (1) GR3022359T3 (sk)
HU (1) HUT74069A (sk)
NO (1) NO952017D0 (sk)
NZ (1) NZ258144A (sk)
PL (1) PL309037A1 (sk)
RU (1) RU95113421A (sk)
SK (1) SK68195A3 (sk)
TW (1) TW254938B (sk)
WO (1) WO1994012484A1 (sk)
ZA (1) ZA938728B (sk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698582A (en) * 1991-07-08 1997-12-16 Rhone-Poulenc Rorer S.A. Compositions containing taxane derivatives
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5677470A (en) 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
CA2170661A1 (en) * 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
AU739303B2 (en) 1997-08-21 2001-10-11 Florida State University Method for the synthesis of taxanes
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1562927B1 (en) * 2002-10-09 2009-05-13 Chatham Biotec Ltd. Thio-analogues of paclitaxel and intermediates thereof
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
FR2986526A1 (fr) 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
WO1994012484A1 (fr) 1994-06-09
DK0669916T3 (da) 1997-02-10
NZ258144A (en) 1996-10-28
TW254938B (sk) 1995-08-21
CZ131795A3 (en) 1995-10-18
EP0669916A1 (fr) 1995-09-06
FR2698363B1 (fr) 1994-12-30
EP0669916B1 (fr) 1997-01-22
HUT74069A (en) 1996-10-28
FI952482A (fi) 1995-05-24
ES2096440T3 (es) 1997-03-01
AU5565994A (en) 1994-06-22
DE69307730T2 (de) 1997-06-05
FI952482A0 (fi) 1995-05-22
AU680455B2 (en) 1997-07-31
US5606083A (en) 1997-02-25
KR950704286A (ko) 1995-11-17
DE69307730D1 (de) 1997-03-06
ATE148111T1 (de) 1997-02-15
RU95113421A (ru) 1997-03-20
SK68195A3 (en) 1995-10-11
PL309037A1 (en) 1995-09-18
GR3022359T3 (en) 1997-04-30
NO952017L (no) 1995-05-22
FR2698363A1 (fr) 1994-05-27
HU9501500D0 (en) 1995-07-28
NO952017D0 (no) 1995-05-22
JPH08503486A (ja) 1996-04-16
CA2149758A1 (fr) 1994-06-09

Similar Documents

Publication Publication Date Title
TW254938B (sk)
RU2329043C2 (ru) Соединения, воздействующие на глюкокиназу
AU5115293A (en) Method of preparing taxane derivatives
AU2741895A (en) Taxoids, preparation and pharmaceutical compositions containing them
CZ131095A3 (en) Process for preparing 1,3-oxazolidine-5-carboxylic acid
GB9523493D0 (en) Preparation of allyl succinate derivatives and starting materials therefore